Contact  : +34 91 452 49 41 | info@algenex.es
ALGENEX is a biotechnology company focused on development of recombinant products and technologies to improve Human and Animal Health. We develop recombinant vaccines, diagnostic and therapeutic molecules, eliminating the costly process of fermentation through efficient use of insects as small live bioreactors.
ALGENEX has proprietary platform technologies to improve recombinant protein production and vaccines efficacy, as well as well differentiated products in the field of vaccines, diagnostic and therapeutic molecules. IBES® technology, APCH1 “inteligent” adjuvant or Top-Bac baculoviruses represent breakthrough developments for the pharmaceutical industry.
Our business model contemplates alliances and joint ventures with companies that have the capability and interest in co-development of new products and/or have the regional or global market presence to successfully promote our products.
ALGENEX was created to connect research and application as straightforwardly and time-efficiently as possible. We consider that helping underprivileged societies, through major cost reduction, to gain access to technological products that will improve their health and their economy, is our contribution to society.